Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies

Abstract Background Glaucoma Research Foundation's third Catalyst for a Cure team (CFC3) was established in 2019 to uncover new therapies for glaucoma, a leading cause of blindness. In the 2021 meeting “Solving Neurodegeneration,” (detailed in Mol Neurodegeneration 17(1), 2022) the team examined the...

Descripció completa

Dades bibliogràfiques

Autors principals:	Emily L. Ward, Larry Benowitz, Thomas M. Brunner, Guojun Bu, Michel Cayouette, Valeria Canto‐Soler, Sandro Dá Mesquita, Adriana Di Polo, Aaron DiAntonio, Xin Duan, Jeffrey L. Goldberg, Zhigang He, Yang Hu, Shane A. Liddelow, Anna La Torre, Milica Margeta, Francisco Quintana, Karthik Shekhar, Beth Stevens, Sally Temple, Humsa Venkatesh, Derek Welsbie, John G. Flanagan
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-10-01
Col·lecció:	Molecular Neurodegeneration
Matèries:	Glaucoma Neurodegeneration Alzheimer’s Disease Parkinson’s Disease Neuroprotection Neuroinflammation
Accés en línia:	https://doi.org/10.1186/s13024-025-00858-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!